Biological readouts for the SAR study included inhibition of colony formation within human cancer cell lines, selective inhibition of cell viability in cancer cell lines, inhibition of Hsp90 activity, and in vitro assessment of pharmacokinetic parameters (solubility and metabolic stability). The gene discussed is HSP90AB1; the disease is cancer.